LINA HABER: Open Payments
NPI 1124183231 · ORANGEBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 26 payments from 10 companies in 2025. Trend: 2023 $713 · 2024 $826 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $223 |
| Janssen Pharmaceuticals, Inc | 4 | $124 |
| Teva Pharmaceuticals USA, Inc. | 4 | $96 |
| Alkermes, Inc. | 3 | $86 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Indivior Inc. | 2 | $33 |
| Luye Pharma (USA) Ltd. | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Lundbeck LLC | 1 | $14 |
Products named: VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR, ARISTADA, ABILIFY MAINTENA, SUBLOCADE, VIVITROL, REXULTI.
Industry payments across NY — which companies pay providers there.
